Study blood and imaging features in older adults with liver cancer
Part of Cancer, Digestive system clinical trials.
This study looks at what liver cancer is like in newly diagnosed people who are older and whose cancer cannot be removed by surgery. It may help doctors better understand disease behavior and how treatments may work and affect the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a new diagnosis of hepatocellular carcinoma confirmed on scan (CT or MRI) or biopsy
- You are 18 years or older
- Your liver cancer is advanced and cannot be removed with surgery (unresectable) based on your doctor
- Your cancer cannot be treated with local procedures (such as locoregional therapy) that would still be planned
- You have not already had treatment that goes through the whole body (systemic) or targeted procedures to the liver (locoregional)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a simple blood test (GAAD score) to a routine liver ultrasound can find early-stage liver cancer sooner in people with chronic liver conditions. It aims to improve detection in Asian populations at risk.
This trial is testing a new way to screen for liver cancer in people with cirrhosis or chronic hepatitis B. It aims to find cancer earlier so it can be treated more effectively.
This study evaluates a special health assessment designed for patients aged 70 and older who are having surgery to remove liver cancer. The goal is to help doctors better prepare older patients for surgery and improve their outcomes.
This study looks at whether adding a blood test (the GAAD score) to standard imaging can better detect liver cancer at an early stage in people with chronic liver disease. It may help you if you have cirrhosis or certain types of liver scarring.
This study tests a new way to screen for liver cancer in people with chronic liver disease, especially those with cirrhosis or significant liver scarring. It uses blood tests and imaging to catch cancer early.
This study is developing a simple screening tool to help doctors better understand the overall health and needs of older cancer patients (65+). It aims to make sure elderly patients get the right support during cancer treatment.
Hear when a new Carcinoma, Hepatocellular trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.